GOLDMAN SACHS GROUP INC - AEGERION PHARMACEUTICALS INC ownership

AEGERION PHARMACEUTICALS INC's ticker is AEGR and the CUSIP is 00767E102. A total of 101 filers reported holding AEGERION PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.47 and the average weighting 0.2%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of AEGERION PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2016$649,000
+54.2%
218,481
-22.6%
0.00%
Q2 2016$421,000
-61.4%
282,416
-4.2%
0.00%
Q1 2016$1,090,000
-33.0%
294,691
+82.8%
0.00%
Q4 2015$1,628,000
-47.4%
161,205
-29.1%
0.00%
-100.0%
Q3 2015$3,093,000
-29.7%
227,408
-2.0%
0.00%0.0%
Q2 2015$4,400,000
-61.5%
231,940
-46.9%
0.00%
-75.0%
Q1 2015$11,431,000
-69.7%
436,809
-75.8%
0.00%
-66.7%
Q4 2014$37,781,000
+21.3%
1,804,220
+93.4%
0.01%
+20.0%
Q3 2014$31,136,000
+424.6%
932,795
+404.4%
0.01%
+400.0%
Q2 2014$5,935,000
-89.1%
184,920
-84.3%
0.00%
-88.9%
Q1 2014$54,355,000
+17.8%
1,177,029
+81.0%
0.02%
+20.0%
Q4 2013$46,150,000
+6892.4%
650,368
+8356.2%
0.02%
Q3 2013$660,000
-15.9%
7,691
-38.0%
0.00%
Q2 2013$785,000
-86.7%
12,397
-94.7%
0.00%
-100.0%
Q4 2012$5,901,000
+756.5%
232,487
+400.5%
0.00%
Q3 2012$689,000
+216.1%
46,450
+216.5%
0.00%
Q2 2012$218,000
+18.5%
14,675
+10.3%
0.00%
Q1 2012$184,00013,3070.00%
Other shareholders
AEGERION PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Sarissa Capital Management LP 1,637,455$42,852,0009.04%
Broadfin Capital, LLC 2,502,578$65,492,0005.10%
SCOPIA CAPITAL MANAGEMENT LP 5,349,840$140,005,0003.03%
HighVista Strategies LLC 265,110$6,938,0001.11%
Perceptive Advisors 381,100$9,973,0000.78%
Healthcare Value Capital, LLC 25,000$654,0000.71%
ADVENT INTERNATIONAL, L.P. 347,001$9,081,0000.70%
Birchview Capital, LP 46,000$1,204,0000.63%
NORTH TIDE CAPITAL, LLC 300,000$7,851,0000.59%
WESTFIELD CAPITAL MANAGEMENT CO LP 2,323,633$60,809,0000.35%
View complete list of AEGERION PHARMACEUTICALS INC shareholders